1. All Products
  2. SALBUTAMOL, 2mg/ml, 2.5ml, sol. for nebulizer, monodose
Public Pricelist

SALBUTAMOL, 2mg/ml, 2.5ml, sol. for nebulizer, monodose

https://medicalguidelines.msf.org/en/node/599
https://unicat.msf.org/cat/product/12297
STD DORASALB2N2

Valid Article

Former Code(s): DORASALB1N-
25.1 - Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
R03AC02
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

SALBUTAMOL solution for nebulizer

Therapeutic Action

Inhaled short-acting beta2 agonist (SABA) bronchodilator

After inhalation, it causes rapid bronchodilation within minutes and lasting for 4-6 hours.

Indications

Severe acute asthma attacks

For symptomatic treatment of asthma attack, prefer salbutamol via a metered dose inhaler (aerosol).

Instructions for use

Ready-to-use solution for inhalation, in single-dose container, to be given with a nebuliser and a mask.

Method of administration:

  • Assemble the nebuliser according to the manufacturer's instructions.
  • Open the container by twisting the top end vigorously.
  • Squeeze the container to empty it into the nebuliser reservoir.
  • Complete with 0.9% sodium chloride to obtain a total volume of 4 ml in the nebuliser reservoir.
  • Avoid eye contact with the aerosol generated by the nebuliser.
  • With pneumatic nebulisers, the flow of air or oxygen to pulse the solution will be adjusted according to the patient's condition and the manufacturer's recommendations.
  • Nebulisation should not normally exceed 10-20 minutes.
  • After nebulisation, any unused solution remaining in the nebuliser reservoir should be discarded.
  • Follow the manufacturer's instructions for use, cleaning and maintenance of the nebuliser.

Precautions for Use

Only by inhalation route. Never use nebuliser solution by parenteral route.

Do not swallow.

Storage

  • Below 25ºC - Protect from sunlight
  • Single-dose container without preservative. Use immediately after opening.
  • Do not use a partially opened or damaged single-dose container.